Detection and outcome of endocervical atypia in cytology in primary HPV screening programme

Johanna Pulkkinen, Saara Kares, Heini Huhtala, Ivana Kholová

Research output: Contribution to journalArticleScientificpeer-review

1 Downloads (Pure)

Abstract

Most endocervical adenocarcinomas (EAC) are associated with high-risk HPV (hrHPV) infection, with HPV genotypes 16, 18 and 45 accounting for >90% of the cases. Among endocervical glandular lesions, screening with hrHPV test has previously shown to predict the outcome better than cytology, although around one-fifth of the EAC remain negative both in hrHPV testing and cytology. The study consists of two consecutive HPV-primary screening rounds, conducted in 2012–2015 and 2017–2020. Of the 87 women aged 35 to 60 years of age diagnosed with Atypical endocervical cells, NOS or Atypical endocervical cells, favor neoplastic cytology during the first screening round, 63 (72.4%) were hrHPV positive and 24 (27.6%) were hrHPV negative. Among hrHPV positive patients, three EAC, two adenocarcinomas in situ (AIS), one AIS + high-grade intraepithelial lesion (HSIL) and 13 HSIL were found. Of the histologically verified lesions, 68.4% (13/19) were purely of squamous origin. All the EAC and AIS were HPV16 or HPV 18 positive. No high-grade histological lesions were found among the hrHPV negative patients with cytological glandular atypia. A later database search revealed one HPV-negative, gastric-type mucinous EAC that was missed by the HPV primary screening.

Original languageEnglish
Article number2402
JournalDiagnostics
Volume11
Issue number12
DOIs
Publication statusPublished - Dec 2021
Publication typeA1 Journal article-refereed

Keywords

  • Adenocarcinoma in situ
  • Atypical endocervical cells
  • Cytology
  • Endocervical adenocarcinoma
  • HPV
  • Screening

Publication forum classification

  • Publication forum level 1

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Detection and outcome of endocervical atypia in cytology in primary HPV screening programme'. Together they form a unique fingerprint.

Cite this